Poxel Reports Cash and Revenue for the Full Year 2023 and Provides Corporate Update [Yahoo! Finance]
SUMITOMO CHEM UNSP/ADR (SOMMY)
NASDAQ:AMEX Investor Relations:
sumitomo-chem.co.jp/english/ir
Company Research
Source: Yahoo! Finance
This growth trajectory is in line to meet or potentially surpass Sumitomo Pharma's FY 2023 forecast The Company remains focused on securing additional financing to execute its strategic plan in rare diseases: Exclusive advanced discussions with a leading investor to monetize royalties from TWYMEEG ® (Imeglimin) sales in Japan Advanced discussions with several potential partners for its three proprietary products: Imeglimin, PXL065 and PXL770 Cost-saving plan completed end of 2023, with significant reduction in headcount to adapt resources to the Company's current needs Cash runway until March 2024, including tranches already drawn on the equity-linked financing facility with IRIS As of December 31, 2023, cash and cash equivalents were EUR 2.3 million (USD 2.6 million); Poxel generated revenue of EUR 2.0 million for FY 2023 LYON, France, February 15, 2024 BUSINESS WIRE )--Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical comp
Show less
Read more
Impact Snapshot
Event Time:
SOMMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SOMMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SOMMY alerts
High impacting SUMITOMO CHEM UNSP/ADR news events
Weekly update
A roundup of the hottest topics
SOMMY
News
- Sumitomo Pharma Presents Urology and Oncology Data at AUA 2024 Annual Meeting [Yahoo! Finance]Yahoo! Finance
- Poxel Provides a Financial Update for the First Quarter 2024 and Announces the Postponement of its 2023 Full-Year Results Release [Yahoo! Finance]Yahoo! Finance
- China Veterinary Medicine Market Analysis Report 2024-2030, Featuring China Animal Husbandry Industry, Boehringer Ingelheim, Bimeda, Merck, CEVA, Zoetis Services, Virbac and Vetoquinol [Yahoo! Finance]Yahoo! Finance
- Roivant announces $1.5B share buyback, positive Phase 2 data Apr. 02, 2024 9:20 AM ET By: Val Brickates Kennedy , SA News Editor [Seeking Alpha]Seeking Alpha
- Poxel to Report Its 2023 Annual Results by the End of April 2024 [Yahoo! Finance]Yahoo! Finance